Psychiatrists' attitude to antipsychotic depot treatment in patients with first-episode schizophrenia
S Heres, T Reichhart, J Hamann, R Mendel… - European …, 2011 - cambridge.org
ObjectiveDespite good clinical evidence, depot antipsychotics are only seldom prescribed to
patients with first episode schizophrenia. The present study aims at investigating …
patients with first episode schizophrenia. The present study aims at investigating …
Service users' experiences of 'as needed'psychotropic medications in acute mental healthcare settings
Aims. This paper reports a study which aimed to explore service users' views and
experiences of the processes associated with the prescription and administration of 'as …
experiences of the processes associated with the prescription and administration of 'as …
Psychiatric nurses' attitudes towards patient autonomy in depot clinics
B Svedberg, K Lützén - Journal of Advanced Nursing, 2001 - Wiley Online Library
Psychiatric nurses' attitudes towards patient autonomy in depot clinics Aim. The aim of this
qualitative study was to explore how psychiatric nurses experience patient autonomy in …
qualitative study was to explore how psychiatric nurses experience patient autonomy in …
[HTML][HTML] Psychopharmacology: underuse of evidence-based treatments in psychiatry
M Fayek, C Flowers, D Signorelli… - Psychiatric …, 2003 - Am Psychiatric Assoc
Psychopharmacology chotics and found similar rates of side effects in the two groups.
Despite evidence of the effectiveness of depot medications, the administration of these …
Despite evidence of the effectiveness of depot medications, the administration of these …
Community treatment orders and antipsychotic long-acting injections
TJ Lambert, BS Singh, MX Patel - The British Journal of Psychiatry, 2009 - cambridge.org
BackgroundThe community treatment order (CTO) is the legal framework by which people in
the community are compelled to accept treatment. Both antipsychotic long-acting injections …
the community are compelled to accept treatment. Both antipsychotic long-acting injections …
Practice nurses and the care of patients receiving depot neuroleptic treatment: views on training, confidence and use of structured assessment
E Millar, C Garland, F Ross… - Journal of Advanced …, 1999 - Wiley Online Library
Practice nurses and the care of patients receiving depot neuroleptic treatment: views on
training, confidence and use of structured assessment The movement of care into the …
training, confidence and use of structured assessment The movement of care into the …
Neuropharmacology and mental health nurse prescribers
D Skingsley, EJ Bradley, P Nolan - Journal of Clinical Nursing, 2006 - Wiley Online Library
Aims and objectives. To outline the development and content of a 'top‐up'
neuropharmacology module for mental health nurse prescribers and consider how much …
neuropharmacology module for mental health nurse prescribers and consider how much …
Relapse and rehospitalization: comparing oral and depot antipsychotics
NR Schooler - Journal of Clinical Psychiatry, 2003 - psychiatrist.com
A review of studies that compared conventional oral and depot antipsychotic medications
highlighted the following points. Mirror-image studies in which patients served as their own …
highlighted the following points. Mirror-image studies in which patients served as their own …
Clinical decision‐making for 'as needed'medications in mental health care
K Usher, JA Baker, C Holmes… - Journal of Advanced …, 2009 - Wiley Online Library
Title. Clinical decision‐making for 'as needed'medications in mental health care. Aim. This
paper is a report of a study exploring the medical and nursing decision‐making process …
paper is a report of a study exploring the medical and nursing decision‐making process …
[PDF][PDF] Depot antipsychotics: Where do we stand?
AY Khan, S Salaria, M Ovais, GD Ide - , 28, 4, 2016 - researchgate.net
BACKGROUND: Nonadherence to medication is a major problem for patients with
schizophrenia. To counter this problem, pharmaceutical companies began developing depot …
schizophrenia. To counter this problem, pharmaceutical companies began developing depot …